US BROKER MOVES: URBN upgraded at Goldman Sachs; HUBS downgraded at Wells Fargo

UPGRADES

Akari Therapeutics (AKTX) Upgraded to Buy at Maxim Group; PT USD 30
FRVO (FRVO) Upgraded to Buy at Jefferies; PT USD 34 (prev USD 41)
Global Payments (GPN) Upgraded to Overweight at Morgan Stanley; PT USD 100 (prev USD 65)
Harley-Davidson (HOG) Upgraded to Buy at Loop Capital
Lumentum (LITE) Upgraded to Overweight at Barclays; PT USD 1,000
Nebius Group (NBIS) Upgraded to Buy at Freedom Capital; PT USD 200 (prev USD 159)
Netflix (NFLX) Upgraded to Buy at Phillip Securities; PT USD 110
Urban Outfitters (URBN) Upgraded to Buy at Goldman Sachs; PT USD 93 (prev USD 76)
U.S. Bancorp (USB) Upgraded to Outperform at Evercore ISI; PT USD 72 (prev USD 65)
U.S. Bancorp (USB) Upgraded to Neutral at JPMorgan; PT USD 67.50 (prev USD 65)
YETI Holdings (YETI) Upgraded to Buy at Goldman Sachs; PT USD 63 (prev USD 46)

DOWNGRADES

Allegro MicroSystems (ALGM) Downgraded to Equalweight at Barclays; PT USD 48
atai Life Sciences (ATAI) Downgraded to Hold at Berenberg
atai Life Sciences (ATAI) Downgraded to Neutral at H.C. Wainwright; PT USD 7.50
Birkenstock (BIRK) Downgraded to Neutral at Seaport Global Securities
Charles River Laboratories (CRL) Downgraded to Hold at CLSA; PT USD 219
Fidus Investment (FDUS) Downgraded to Market Perform at Keefe, Bruyette & Woods; PT USD 19.50
F.N.B. Corporation (FNB) Downgraded to Neutral at BofA Securities; PT USD 19 (prev USD 20)
HubSpot (HUBS) Downgraded to Equal Weight at Wells Fargo; PT USD 225 (prev USD 300)
Monster Beverage (MNST) Downgraded to Hold at Deutsche Bank; PT USD 98 (prev USD 94)
Pengu (PENG) Downgraded to Underweight at Barclays; PT USD 40
Charles Schwab (SCHW) Downgraded to Market Perform at BMO Capital; PT USD 105
StoneX Group (SNEX) Downgraded to Hold at Jefferies; PT USD 112 (prev USD 123)
Truist Financial (TFC) Downgraded to Underweight at JPMorgan; PT USD 53 (prev USD 53.50)

INITIATIONS

Adobe (ADBE) Initiated Outperform at CLSA; PT USD 300
AerCap Holdings (AER) Initiated Buy at Citi; PT USD 173
AN2 Therapeutics (ANTX) Initiated Buy at Guggenheim; PT USD 9
Apollo Global Management (APO) Initiated Buy at HSBC; PT USD 145
Apollo Global Management (APO) Initiated Market Perform at Keefe, Bruyette & Woods; PT USD 130
Ares Management (ARES) Initiated Market Perform at Keefe, Bruyette & Woods; PT USD 122
Broadway Financial (BWAY) Initiated Buy at BTIG; PT USD 18
Crane (CR) Initiated Outperform at BMO Capital; PT USD 253
Salesforce (CRM) Initiated Hold at CLSA; PT USD 165
DPC (DPC) Initiated Buy at Rothschild Redburn; PT USD 53.50
DPC (DPC) Initiated Buy at Jefferies; PT USD 56
DPC (DPC) Initiated Equalweight at Morgan Stanley; PT USD 47
DPC (DPC) Initiated Outperform at RBC Capital; PT USD 53
Microsoft (MSFT) Initiated Outperform at CLSA; PT USD 535
NN (NNBR) Initiated Buy at Craig-Hallum; PT USD 7
ServiceNow (NOW) Initiated Underperform at CLSA; PT USD 72
Enpro (NPO) Initiated Overweight at JPMorgan; PT USD 420
Oracle (ORCL) Initiated Hold at CLSA; PT USD 145
Ralliant (RAL) Initiated Market Perform at BMO Capital; PT USD 78
ReNetX Bio (RNTX) Initiated Buy at Maxim Group; PT USD 4
Regal Rexnord (RRX) Initiated Buy at Deutsche Bank; PT USD 286
Shell (SHEL) Initiated Neutral at Mizuho; PT USD 98
Soluna Holdings (SLNH) Initiated Buy at H.C. Wainwright; PT USD 4
SOPHiA GENETICS (SOPH) Initiated Buy at H.C. Wainwright; PT USD 12
Sportradar (SRAD) Initiated Buy at Freedom Capital; PT USD 20
Neuronetics (STIM) Initiated Buy at BTIG; PT USD 5
Starkey (STTK) Initiated Outperform at Leerink; PT USD 16
TotalEnergies (TTE) Initiated Outperform at Mizuho; PT USD 103
TTRX (TTRX) Initiated Buy at Ladenburg Thalmann; PT USD 26
Vangent (VGNT) Initiated Buy at Goldman Sachs; PT USD 48
Workday (WDAY) Initiated Underperform at CLSA; PT USD 92